Evidence map›Paper›PMID 25271633›Full record

ArticlePloS one2014

Olfactory dysfunction predicts 5-year mortality in older adults.

Jayant M Pinto, Kristen E Wroblewski, David W Kern, L Philip Schumm, Martha K McClintock

6 registry-linked trialsAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 190 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04700891 nacompletednot on this mapstarted 2020, after this paper: background citation

Correlation of Preoperative Olfactory Identification Function With Preoperative Frailty and With Postoperative Complications and Mortality Following Elective Surgery

TypeinterventionalSponsorCliniques universitaires Saint-Luc- Université Catholique de LouvainRan2020 to 2022Enrolled167ConditionsFrailty, Perioperative/Postoperative Complications, Olfactory DisorderArmsOlfactory identification test, Edmonton Frail Scale, Handgrip strength
NCT04761458 nacompletednot on this mapstarted 2021, after this paper: background citation

Correlation of Preoperative Global Olfactory Function With Frailty, Preoperative Cognitive Status, Postoperative Neurocognitive Disorders and Mortality Following Elective Surgery

TypeinterventionalSponsorCliniques universitaires Saint-Luc- Université Catholique de LouvainRan2021 to 2023Enrolled215ConditionsFrailty, Perioperative/Postoperative Complications, Olfactory Disorder, Neurocognitive DisordersArmsOlfactory function testing, Edmonton Frail Scale, Clinical Frailty Scale, Neuropsychological test battery
NCT04789499 phase2completednot on this mapstarted 2021, after this paper: background citation

Smell in Covid-19 and Efficacy of Nasal Theophylline

TypeinterventionalSponsorWashington University School of MedicineRan2021 to 2021Enrolled51ConditionsCovid19, Anosmia, Olfactory Disorder, Covid-19 PandemicArmsTheophylline Powder, Placebo Comparator
NCT05216614 phase2withdrawnnot on this mapstarted 2021, after this paper: background citation

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia (FluCOP Trial)

TypeinterventionalSponsorWashington University School of MedicineRan2021 to 2022Enrolled0ConditionsCOVID-19, Olfactory Disorder, ParosmiaArmsFluvoxamine, Placebo
NCT05947643 phase2completednot on this mapstarted 2022, after this paper: background citation

Smell in COVID-19 and Efficacy of Nasal Theophylline 3

TypeinterventionalSponsorWashington University School of MedicineRan2022 to 2025Enrolled77ConditionsCOVID-19Armstheophylline, Placebo
NCT06498687 phase1withdrawnnot on this mapstarted 2025, after this paper: background citation

A Single-Arm Study to Evaluate the Feasibility of CYR-064 Theophylline Nasal Spray for the Treatment of Parkinson's Disease Related Hyposmia and Anosmia

TypeinterventionalSponsorUniversity of NebraskaRan2025 to 2026Enrolled0ConditionsHyposmia, AnosmiaArmsCYR-064
3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Need to Promote Olfactory Health in Public Health Agendas Across the Globe.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026
    Review
  19. Article
  20. Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jayant M PintoSection of Otolaryngology-Head and Neck Surgery, Department of Surgery, The University of Chicago, Chicago, Illinois, United States of America.
Kristen E WroblewskiDepartment of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
David W KernDepartment of Comparative Human Development and The Institute for Mind and Biology, The University of Chicago, Chicago, Illinois, United States of America; The Center on the Demography and Economics of Aging, National Opinion Research Center, The University of Chicago, Chicago, Illinois, United States of America.
L Philip SchummDepartment of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
Martha K McClintockDepartment of Comparative Human Development and The Institute for Mind and Biology, The University of Chicago, Chicago, Illinois, United States of America; The Center on the Demography and Economics of Aging, National Opinion Research Center, The University of Chicago, Chicago, Illinois, United States of America.

Funding

TRANSLATIONAL RESEARCH UNIVERSITY OF CHICAGO: CLINICAL TRIALSUL1RR024999 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$25.3M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
National Social Life, Health, and Aging Project: Anaylsis of Wave 1 and Wave 2R37AG030481 · NIA · NATIONAL OPINION RESEARCH CENTER · PI WAITE, LINDA J · 2008 to 2017
$15.4M
National Social Life, Health and Aging Project (RMI)R01AG021487 · NIA · NATIONAL OPINION RESEARCH CENTER · PI WAITE, LINDA J · 2003 to 2007
$12.2M
NSHAP Wave II Partner Data CollectionR01AG033903 · NIA · NATIONAL OPINION RESEARCH CENTER · PI WAITE, LINDA J · 2009 to 2013
$5.8M
Re-Engineering Translational Research at The University of Chicago (KL2)KL2RR025000 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$2.0M
Short Term Aging-Related Research ProgramT35AG029795 · NIA · UNIVERSITY OF CHICAGO · PI Vineet Arora, DAVID O MELTZER · 2008 to 2026
$1.4M
Understanding Susceptibility to Olfactory Decline in AgingK23AG036762 · NIA · UNIVERSITY OF CHICAGO · PI PINTO, JAYANT M · 2012 to 2014
$457k
NCATS NIH HHS UL1 TR000430NCRR NIH HHS KL2 RR025000NCRR NIH HHS KL2RR025000NCRR NIH HHS UL1 RR024999NCRR NIH HHS UL1RR024999NIA NIH HHS AG021487NIA NIH HHS AG029795NIA NIH HHS AG030481NIA NIH HHS AG033903-01NIA NIH HHS AG036762NIA NIH HHS K23 AG036762NIA NIH HHS R01 AG021487NIA NIH HHS R01 AG033903NIA NIH HHS R37 AG030481NIA NIH HHS T35 AG029795PHS HHS T32000243
6 · The paper itself

Abstract

Prediction of mortality has focused on disease and frailty, although antecedent biomarkers may herald broad physiological decline. Olfaction, an ancestral chemical system, is a strong candidate biomarker because it is linked to diverse physiological processes. We sought to determine if olfactory dysfunction is a harbinger of 5-year mortality in the National Social Life, Health and Aging Project [NSHAP], a nationally representative sample of older U.S. adults. 3,005 community-dwelling adults aged 57-85 were studied in 2005-6 (Wave 1) and their mortality determined in 2010-11 (Wave 2). Olfactory dysfunction, determined objectively at Wave 1, was used to estimate the odds of 5-year, all cause mortality via logistic regression, controlling for demographics and health factors. Mortality for anosmic older adults was four times that of normosmic individuals while hyposmic individuals had intermediate mortality (p<0.001), a "dose-dependent" effect present across the age range. In a comprehensive model that included potential confounding factors, anosmic older adults had over three times the odds of death compared to normosmic individuals (OR, 3.37 [95%CI 2.04, 5.57]), higher than and independent of known leading causes of death, and did not result from the following mechanisms: nutrition, cognitive function, mental health, smoking and alcohol abuse or frailty. Olfactory function is thus one of the strongest predictors of 5-year mortality and may serve as a bellwether for slowed cellular regeneration or as a marker of cumulative toxic environmental exposures. This finding provides clues for pinpointing an underlying mechanism related to a fundamental component of the aging process.

Indexed as

AgedAged, 80 and overAge FactorsComorbidityFemaleHumansMaleMiddle AgedOdds RatioOlfaction DisordersOlfactory BulbPopulation SurveillanceRisk FactorsSmell

Identifiers

PMID25271633
PMCPMC4182669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.